Physician profile
Caroline Conner
NPI 1538373725
$2,583.66
in general payments reported to CMS, 2019-2025
22 companies · $23.74 in 2025
The $23.74 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $247 · 2021: $924 · 2022: $746 · 2023: $118 · 2024: $36.38 · 2025: $23.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $808.61 | 2019-2024 | Liletta, Lo Loestrin Fe |
| Avion Pharmaceuticals | $390.12 | 2021 | |
| Therapeuticsmd, INC. | $195.70 | 2019-2022 | |
| Novo Nordisk INC | $191.16 | 2022-2023 | Ozempic, Rybelsus |
| Allergan, INC. | $157.13 | 2019-2020 | |
| Hologic Sales and Service, LLC | $148.05 | 2019-2023 | Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $121.75 | 2021 | |
| Organon LLC | $105.49 | 2021-2022 | |
| Evofem Biosciences, INC. | $73.30 | 2021-2025 | Solosec, Phexx, Phexxi |
| Mayne Pharma Commercial LLC | $47.23 | 2019-2023 | |
| Pfizer INC. | $44.35 | 2019-2020 | |
| Lupin INC. | $44.01 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.64 | 2019-2020 | |
| Myovant Sciences INC. | $40.72 | 2021 | |
| Vertical Pharmaceuticals, LLC | $36.15 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $30.71 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $25.43 | 2022 | |
| Channel Medsystems, INC. | $20.78 | 2022 | |
| Currax Pharmaceuticals LLC | $16.83 | 2021 | |
| Glaxosmithkline, LLC. | $16.47 | 2025 | Nucala |
| Bayer Healthcare Pharmaceuticals INC. | $15.55 | 2019 | |
| Daiichi Sankyo INC. | $12.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.